Patient Care

This page includes news coverage of various aspects of patient healthcare, including new technology innovations, what is working, what is not, personalized medicine and remote and telemedicine delivery. Find specific news in the areas of Care DeliveryDigital TransformationPrecision MedicineRemote Monitoring and Telehealth.

Thumbnail

AI model for pneumothorax gains FDA clearance

behold.ai, a London-based imaging technology company, has received FDA clearance for its AI algorithm designed to help radiologists triage pneumothorax patients.

Thumbnail

150M Americans could contract coronavirus

The new coronavirus could infect between 70 million and 150 million people in the U.S., according to the attending physician of Congress and the Supreme Court, Brian Monahan. 

Thumbnail

It’s now or never: Why family medicine physicians must finally embrace AI

AI’s impact on healthcare continues to grow, with specialties such as radiology and cardiology fully embracing the technology’s potential to modify workflows and improve patient outcomes. Family medicine physicians, however, have been slow to embrace this growing trend.

Thumbnail

ACR publishes coronavirus use case to help AI researchers

The American College of Radiology Data Science Institute (ACR DSI) has shared an AI use case for the new coronavirus, publishing it just as the World Health Organization declared COVID-19 a pandemic.

Thumbnail

Non-US citizens less likely to receive treatment for CV ills

U.S.-born and -naturalized citizens are far more likely than noncitizens to receive treatment for CVD risk factors, researchers reported in Circulation this month.

Thumbnail

RadNet to increase AI presence with acquisition of DeepHealth

RadNet, one of the largest radiology providers in the United States, has entered into a definitive agreement to acquire DeepHealth, an imaging technology company focused on using AI to improve breast cancer screening.  

Thumbnail

Tracking China’s response to the coronavirus outbreak

Researchers are using advanced technology—including AI, natural language processing (NLP) and satellite imaging—to track how the new coronavirus has impacted China.

Thumbnail

Will AI’s ‘black box’ problem ever be solved?

Researchers still don’t truly understand how these algorithms work—and that’s a significant issue.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.